Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Valentina Zipoli"'
Autor:
Diego Centonze, Roberta Fantozzi, Fabio Buttari, Luigi Maria Edoardo Grimaldi, Rocco Totaro, Francesco Corea, Maria Giovanna Marrosu, Paolo Confalonieri, Salvatore Cottone, Maria Trojano, Valentina Zipoli
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Subcutaneous (SC) interferons beta (IFN-beta) are effective therapies for the treatment of relapsing–remitting multiple sclerosis (RRMS). Factors such as dosing schedule, needle intolerance/fatigue, and side effects may impact patient satisfaction
Externí odkaz:
https://doaj.org/article/7d70a0f6b54f4ff496b2b46dee86bdc0
Autor:
Vincenzo Brescia Morra, Maria Pia Amato, Giovanna Borriello, Benedetta Goretti, Marco Onofrj, Mauro Zaffaroni, Paolo Gallo, Valentina Zipoli, Maria Trojano, Eleonora Cocco
Publikováno v:
Neurological Sciences. 41:3185-3193
A significant proportion of patients with multiple sclerosis (MS) show cognitive impairment. To evaluate the effect of 2-year treatment with oral dimethyl fumarate (DMF) on cognition in relapsing remitting MS (RRMS). In this prospective single-arm st
Autor:
Graziella Callari, Giuseppe Martucci, Cinzia Cordioli, Roberta Fantozzi, Francesca Caruso, Santa Mascara, Valentina Zipoli
Publikováno v:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 42(4)
Peginterferon beta-1a (Plegridy) offers the advantage of a prolonged half-life with less-frequent administration and a higher patient adherence. However, the use of an interferon may lead to flu-like symptoms (FLS) and injection-site reactions (ISR)
Autor:
Silvia Masera, Francesco Patti, Rocco Totaro, Nicola Rossi, Vincenzo Brescia Morra, Valentina Zipoli, Cinzia Scandellari, Want Investigators, Ruggero Capra, Massimiliano Mirabella, Claudio Gasperini
The Work Ability in Natalizumab-Treated MS Patients (WANT) study assessed work ability, quality of life, and cognitive processing speed during natalizumab treatment. WANT was a 1-year, prospective, multicenter observational study conducted in Italy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed0659c773c8537f49b55a7842be62c1
http://hdl.handle.net/10807/165222
http://hdl.handle.net/10807/165222
Autor:
Lucia Moiola, Maria Buccafusca, Massimiliano Mirabella, BREMSO-group, Valentina Zipoli, Roberto Bergamaschi, Gianluca Moscato, Vincenzo Brescia Morra, Elisabetta Ferraro, Katrin Plewnia, Mauro Zaffaroni, Maria Pia Amato, Giulia Mallucci, Francesco Patti, Maria Trojano, Elisa Puma
Disease modifying therapy have changed the natural evolution of multiple sclerosis (MS), with efficacy demonstrated in randomized clinical trials. Standard-of-care effectiveness is needed to complement clinical trial data and highlight outcomes in re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4636ecaab3c9713fc1583fd29a78ce93
http://hdl.handle.net/20.500.11769/381250
http://hdl.handle.net/20.500.11769/381250
Autor:
Cinzia Cordioli, Graziella Callari, Roberta Fantozzi, Francesca Caruso, Giuseppe Martucci, Santa Mascara, Valentina Zipoli
Publikováno v:
Neurological Sciences. 42:1637-1637
Publikováno v:
Quaderni Italiani di Psichiatria. 31:26-31
Riassunto Introduzione La scala espansa di disabilita (Expanded Disability Status Scale, EDSS) e uno strumento per la misura e il monitoraggio dell’evoluzione della disabilita nella sclerosi multipla, introdotto da Kurtzke nel 1983. Prevede l’att
Publikováno v:
Neurological Sciences. 31:227-230
Multiple sclerosis (MS) is a chronic inflammatory disorder of the central nervous system typically affecting young adults. Psychological coping has proved to be crucially important for adjusting to the adaptive demands of chronic diseases, and in the
Autor:
Maria Trojano, Paolo Rossi, Carlo Avolio, Enrico Millefiorini, Vito Lepore, G. Comi, Damiano Paolicelli, C. Tortorella, Isabella Laura Simone, Valentina Zipoli, Alessandra Lugaresi, A Fuiani, Carlo Pozzilli, Giacomo Lus, Roberto Bergamaschi, Giuseppe Salemi, Marinella Clerico, M. P. Amato, Francesco Patti, A. Ghezzi, Fabio Pellegrini, Paolo Livrea, G. B. Zimatore, Paola Cavalla, M. Vianello
Publikováno v:
Annals of Neurology. 66:513-520
Objective: Recent findings support greater efficacy of early vs. delayed interferon beta (IFN) treatment in patients with a first clinical event suggestive of multiple sclerosis (MS). We aimed to evaluate the effectiveness of early IFN treatment in d
Autor:
Bahia Hakiki, Benedetta Goretti, Gianfranco Siracusa, Maria Pia Amato, Valentina Zipoli, Sandro Sorbi, Emilio Portaccio
Publikováno v:
Neurological Sciences. 30:15-20
The aim of this study was to assess the impact of psychological features in the choice of coping strategies in multiple sclerosis (MS) patients, and their influence on quality of life (QoL). One hundred four patients (72 women, age 45.3 +/- 10.9 year